Pancreatic beta-cells respond to increasing blood glucose concentrations by secreting the hormone insulin. The dysfunction of beta-cells leads to hyperglycemia and severe, life-threatening consequences. Understanding how the beta-cells operate under physiological conditions and what genetic and environmental factors might cause their dysfunction could lead to better treatment options for diabetic patients. The ability to measure calcium levels in beta-cells serves as an important indicator of beta-cell function, as the influx of calcium ions triggers insulin release. Here we describe a protocol for monitoring the glucose-stimulated calcium influx in zebrafish beta-cells by using GCaMP6s, a genetically encoded sensor of calcium. The method allows monitoring the intracellular calcium dynamics with single-cell resolution in ex vivo mounted islets. The glucose-responsiveness of beta-cells within the same islet can be captured simultaneously under different glucose concentrations, which suggests the presence of functional heterogeneity among zebrafish beta-cells. Furthermore, the technique provides high temporal and spatial resolution, which reveals the oscillatory nature of the calcium influx upon glucose stimulation. Our approach opens the doors to use the zebrafish as a model to investigate the contribution of genetic and environmental factors to beta-cell function and dysfunction.
Introduction
Our blood-glucose is maintained in a narrow range, in large part due to the function of the endocrine pancreas. The endocrine role of the pancreas is performed by the islets of Langerhans, which contain hormone-secreting cells. The insulin-secreting beta-cells are responsible for reducing the levels of blood-glucose following a carbohydrate-containing meal. Inadequate insulin secretion from beta-cell can result in diabetes 1 , which is characterized by sustained high blood-glucose. Type 1 and Type 2 Diabetes, which currently afflicts more than 400 million people worldwide, leads to morbidity and mortality 2 . By investigating the molecular and environmental factors that contribute to beta-cell dysfunction, we will understand better how type 2 diabetes starts and progresses. In addition, the ability to differentiate human stem cells into functional beta-cells in vitro can provide a source of new beta-cells for cell-replacement therapies in Type 1 Diabetes. To this end, it is important to study beta-cell function and maturation in genetic model organisms in order to gain the necessary knowledge for making functional beta-cells in a dish.
Beta-cell functionality can be monitored at the whole-islet level by quantifying the total amount of insulin secreted in response to glucosestimulation. This cumulative approach studies the islet as a single group of cells without differentiating a cell's individual properties. However, the analysis of glucose responses of individual beta-cells revealed a diversity in the functional properties of beta-cells and the presence of heterogeneity 3 . To assess the function of individual beta-cells, it is possible to monitor the intracellular changes that lead to insulin secretion 4 . Insulin secretion is preceded by an entry of glucose into the beta-cells. The glucose that enters in the beta-cells is rapidly metabolized to ATP. Higher intracellular ATP concentrations decrease the open probability of ATP-sensitive potassium ion channels leading to beta-cell depolarization. Depolarization opens the voltage-sensitive calcium ion channels and increases intracellular calcium. In turn, calcium triggers exocytosis of insulin, which is released in the circulation and lowers glucose levels by promoting glucose-utilization 5, 6, 7 .
Several strategies have been applied to investigate the function of beta-cells, including monitoring of the membrane potential 8 , direct visualization of insulin-vesicles exocytosis 9 , and quantification of intracellular Ca 2+ influx as a proxy for glucose-responsiveness 10 . Among them, imaging of intracellular Ca 2+ provides the advantage of up-scaling the analysis to multiple individual cells within the same islet 11, 12 , allowing for direct comparison of the glucose-responsiveness between individual beta-cells. Intracellular Ca 2+ concentration can be monitored using calciumsensitive fluorescent dyes 13 or genetically-encoded calcium indicators (GECIs)
Preparation
NOTE: This protocol is for ex vivo imaging of zebrafish primary islet from double transgenic Tg(ins:nls-Renilla-mKO2; cryaa:CFP); Tg(ins:GCaMP6s; cryaa:mCherry)19 zebrafish. In this transgenic line, the insulin promoter (ins) drives beta-cell specific expression of two transgenes: nls-Renilla-mKO2, which marks the nucleus of beta-cells with monomeric Kusabira orange 2 (mKO2) fluorescence; and GCaMP6s15, which emits green fluorescence in response to increase in intracellular calcium levels. The beta-cell-specific expression of GCaMP6s enables studying the glucose-responsiveness of beta-cells without interference from calcium changes in surrounding cell types. 
Zebrafish Primary Islet Dissection and Mounting
1. Euthanize a fish using prolonged incubation in MS222. For this, gently remove the fish from the fish tank using a fishing net and incubate it in a Petri dish containing the MS222 solution until the animal shows no opercular (gills) movement; typically, this takes 5 min. Transfer the fish to a Petri dish containing the HBSS solution with Ca 2+ /Mg 2+ . 2. Under a stereo microscope equipped with a fluorescence lamp and red filter cube, dissect the skin covering the right side of the abdomen of the animal to isolate the pancreas. 1. For this, cut the skin of the zebrafish from mouth to anal fin using sharp forceps. Peel away the cut skin to expose the abdomen; this snipping exposes the internal organs. By using the red fluorescence of mKO2 expression in beta-cells, ascertain the location of the islets by visual examination under the microscope. If needed, remove the lobes of the liver, as they could cover the islet, making it difficult to find. NOTE: The primary islet is located near the anterior region of the abdomen, typically on the right side.
3. Clean the primary islet by carefully removing surrounding tissue such as liver and adipocytes. Take precaution not to injure or poke the islet; after clearing of the surrounding tissue, the individual cells on the islet surface become discernable. 4. Pipette a 30 µL drop of HBSS onto the center of a glass-bottom dish. Transfer the dissected islet to this drop. 5. Carefully wash the islet once with HBSS and once with 30 µL of the fibrinogen working solution (3.3 mg/mL). Make sure to avoid drying of the islet during the washing steps because failure to do so results in cell death. 6. Slowly and gently add 10 µL of the thrombin solution (10 U/mL). Leave the islet and the dish untouched for 15-20 min. Observe that the fibrinogen-thrombin drop will become viscous and slightly opaque at this point.
Ex Vivo Live-imaging of GCaMP Fluorescence Intensity in Zebrafish Primary Islets
1. Open the image file in FIJI using the "LSM Toolbox". For this, select "Plugin | LSM Toolbox | Show LSM toolbox". In the "LSM Toolbox", click "Open LSM" and select the image file. Note: For formats not supported by the "LSM Toolbox", convert them first to tiff for analysis. 2. Extract the responses of cells using the region-of-interest (ROI) tool in FIJI. Open the "ROI Manager" in the "Analyze" menu under "Tools".
Manually draw the ROI using the "polygon selection tool" located in the Toolbar. 3. Draw the ROI in the red channel in which the beta-cell nuclei are visible. Select the ROI such that it covers an area that is larger than a cell's nucleus in order to include some of the cell's cytoplasm. Ensure that the ROI position is consistent between frames and adjust the position if necessary. 4. Add the selected ROIs to the "ROI manager" by clicking on the "Add [t]" button. Select and add multiple ROIs to the ROI for obtaining data on multiple cells. 5. Next, from the "Analyze" menu, select "Set measurements". Select "Integrated Density" for specifying extraction of total fluorescence intensity within the area. 6. Shift to the green channel containing the GCaMP fluorescence and select "Multi Measure" in the "ROI Manager".
NOTE: This will provide the intensity measurements for the cells throughout the time-series. 7. In case the ROI position needs to be adjusted due to movement of the islet, manually compile the intensity measurements in different frames.
Copy and paste the values to a separate spreadsheet. 8. Obtain the timestamps of the image frames from "LSM Toolbox". Use "Apply stamps | Apply t stamps | File name | Dump to textfile" to obtain the timestamps. Save timestamps using the "Save as" option, or copy them into the spreadsheet. 9. Upon compiling the intensity values for all cells, perform the analysis one cell at a time or automatically (e.g., using Excel Formulas or R). 10. Analyze individual cells in two steps.
1. In the first step, calculate the fluorescence intensity above the baseline. To this end, calculate the baseline fluorescent intensity (F 0 ) as the average of fluorescence intensities for the first 50 frames (5 mM glucose). Then subtract the baseline (F 0 ) from the entire timeseries (F -F 0 ). NOTE: A few cells can show clear GCaMP oscillations under basal glucose, which typically continue following stimulation with higher concentrations. For such cells, it is only possible to estimate F 0 by taking the mean intensity of the initial frames in which the cells showed a drop in fluorescence. 2. In the second step of the analysis, obtain the final GCaMP fluorescence intensity by normalizing the fluorescence intensity.
NOTE: This is performed to remove the differences between islets from different animals. Individual islets display varying levels of fluorescence emission upon glucose stimulation. 3. Normalize the fluorescence intensity by dividing it with the highest intensity value. For this, calculate the peak intensity (F max -F 0 ), and divide the baseline subtracted values by peak intensity to yield the final GCaMP fluorescence intensity (F -F 0 )/(F max -F 0 ). 
Discussion
Here we demonstrate a technique for the quantification of beta-cell glucose responsiveness at single-cell resolution. This is made possible by monitoring intracellular calcium concentration using a genetically-encoded calcium indicator, GCaMP6s. The beta-cell activity is captured ex vivo by mounting the islet in a fibrinogen-thrombin mold. A critical step of the protocol is the stability of the mold. Sufficient time needs to be given for the fibrinogen to dissolve in the HBSS solution. Without this, the mold does not polymerize sufficiently to provide stability during the imaging session. An islet mounted in fibrinogen-thrombin mold and immersed in cell culture media can remain viable for at least a week (data not shown). Alternatives to the fibrinogen-thrombin mold, such as low-melt agarose, can be utilized to mount the islet 22 . Another critical parameter is the dissection of the islet. During this step, the tissue surrounding the islet needs to be removed without injuring or poking the islet. A skillful dissection comes with practice.
A limitation of the imaging protocol is the restriction to one confocal plane of the islet. This is done to capture the dynamics of calcium influx within individual beta-cells. A Z-stack through the entire thickness of the islet leads to low imaging speeds and loss of oscillatory signal from individual cells. This limitation could be improved by using faster means of confocal-imaging such as spinning-disk microscopy, to enable capturing the calcium dynamics in 3-dimensions. Another frontier would be in vivo calcium imaging 12 . The transparent nature of zebrafish embryo or the use of pigment-less strains of zebrafish adults 23 could open the possibility for in vivo imaging in the future.
The imaging of beta-cell activity at high spatial and temporal resolution enables to investigate the functional heterogeneity among individual betacells. This approach can help shed light on the existence of beta-cell sub-populations. Recently, multiple studies have shown the existence of sub-populations in the nominally homogenous beta-cells 24, 25, 26 . Ex vivo imaging can be combined with genetic reporters to characterize of the sub-population's response to glucose. Additionally, combining the imaging setup with pharmacological stimulation can allow for screening of compounds that could improve beta-cell functionality.
In summary, the technique presented here allows quantification and comparison of the glucose responsiveness for individual beta-cells. It provides a direct window into beta-cell functionality, an important parameter in development of diabetes.
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